Brief: PharmaCyte Biotech Announces Additional Quality Control Assay And Confirms Stability Of CypCap Cells
05/07/2022 13:34
July 5 (Reuters) - PharmaCyte Biotech Inc PMCB.O :
* PHARMACYTE BIOTECH ANNOUNCES ADDITIONAL QUALITY CONTROL
ASSAY
AND CONFIRMS STABILITY OF CYPCAP CELLS
Source text for Eikon: ID:nBw70T85Va
Further company coverage: PMCB.O
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer